Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis
- PMID: 8202877
- PMCID: PMC1021149
- DOI: 10.1136/thx.49.3.218
Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis
Abstract
Background: It has been hypothesised that cryptogenic fibrosing alveolitis has an immunological pathogenesis mediated by T lymphocytes. It is, however, recognised that patients may show dysregulation of the humoral immune system and that the presence of large numbers of B lymphocytes in open lung biopsies may be associated with a poor prognosis. Evidence of a role for the humoral immune system in the pathogenesis of cryptogenic fibrosing alveolitis has been suggested, but attempts to demonstrate circulating immunoglobulin to antigen within the lung have been inconclusive.
Methods: Plasma samples from 22 patients with cryptogenic fibrosing alveolitis, 22 patients with sarcoidosis, and 17 healthy controls were screened by SDS-PAGE and Western blotting for the presence of autoantibodies to lung proteins derived from cryptogenic fibrosing alveolitis, sarcoid and control lung tissue, as well as four normal non-pulmonary tissues. Possible site(s) of target protein(s) within the lung tissue were identified by immunohistochemical examination using IgG purified from the plasma of six patients and two controls.
Results: Eighteen of the plasma samples from patients with cryptogenic fibrosing alveolitis had reactive IgG to lung protein(s) in the 70-90 kDa molecular weight range compared with five of 18 plasma samples from patients with sarcoidosis and one of 17 controls. Plasma from patients with cryptogenic fibrosing alveolitis recognised antigen(s) of the same molecular weight in control and sarcoid lung tissue, but not non-pulmonary tissues, with a similar frequency. Immunohistochemical staining of cryptogenic fibrosing alveolitis biopsy material using IgG purified from plasma samples from patients with cryptogenic fibrosing alveolitis, but not control samples, revealed fine linear positivity in the lung parenchyma in a pattern suggestive of reaction with alveolar lining cells. The pattern was cytoplasmic/membranous and not nuclear.
Conclusions: Patients with cryptogenic fibrosing alveolitis have a high frequency of plasma IgG autoantibodies to protein(s) within lung tissue associated with alveolar lining cells. This is believed to be the site where immunological injury occurs in cryptogenic fibrosing alveolitis, but the significance of these antibodies to the aetiology and pathogenesis is as yet unclear.
Similar articles
-
Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.Thorax. 1994 Nov;49(11):1139-45. doi: 10.1136/thx.49.11.1139. Thorax. 1994. PMID: 7831631 Free PMC article.
-
Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.Thorax. 1995 Dec;50(12):1234-9. doi: 10.1136/thx.50.12.1234. Thorax. 1995. PMID: 8553293 Free PMC article.
-
Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.Thorax. 1998 Nov;53(11):969-74. doi: 10.1136/thx.53.11.969. Thorax. 1998. PMID: 10193397 Free PMC article.
-
Evaluation of alveolitis by studies of lung biopsies.Lung. 1990;168 Suppl:984-92. doi: 10.1007/BF02718236. Lung. 1990. PMID: 2117219 Review.
-
Hypothesis: exposure to solvents may cause fibrosing alveolitis.Eur Respir J. 1994 Jun;7(6):1172-6. Eur Respir J. 1994. PMID: 7925888 Review.
Cited by
-
Idiopathic pulmonary fibrosis and a role for autoimmunity.Immunol Cell Biol. 2017 Aug;95(7):577-583. doi: 10.1038/icb.2017.22. Epub 2017 Mar 30. Immunol Cell Biol. 2017. PMID: 28356570 Review.
-
Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis.Respir Res. 2001;2(2):119-24. doi: 10.1186/rr46. Epub 2001 Feb 20. Respir Res. 2001. PMID: 11686873 Free PMC article.
-
Immunodeficiency of aging.Drugs Aging. 1997 Nov;11(5):374-97. doi: 10.2165/00002512-199711050-00005. Drugs Aging. 1997. PMID: 9359024 Review.
-
Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases.Int J Mol Sci. 2021 Aug 27;22(17):9316. doi: 10.3390/ijms22179316. Int J Mol Sci. 2021. PMID: 34502225 Free PMC article. Review.
-
Molecular and cellular mechanisms of pulmonary fibrosis.Fibrogenesis Tissue Repair. 2012 Jul 23;5(1):11. doi: 10.1186/1755-1536-5-11. Fibrogenesis Tissue Repair. 2012. PMID: 22824096 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical